Literature DB >> 30315629

Psoriasis and suicidality: A review of the literature.

Sydney E Liang1, Jeffrey M Cohen2, Roger S Ho2.   

Abstract

Psoriasis is a chronic systemic inflammatory skin disease, which has been associated with an increased risk of numerous medical and psychiatric comorbidities, including suicidality. Suicidality, which can be divided into the categories of suicidal ideation, suicide attempt, and completed suicide, is highly prevalent in the psoriasis population, and multiple studies have been published on the subject of psoriasis and suicidal ideation and behavior (SIB), including two recent meta-analyses. However, the available literature is limited and inconsistent, and the association between the two remains incompletely understood. The present review aims to cohesively synthesize and summarize the available evidence, while making a clinically relevant distinction between the sub-categories of suicidality, by examining not only the epidemiology of the association but also the plausible molecular mechanisms and the potential influence of biologic therapies. Additionally, this review aims to critically examine and understand the potential contribution of depression in the psoriasis and suicidality relationship. This will allow us to better understand the complex and multi-faceted relationship between psoriasis and suicidality, to identify those who may be most at risk for SIB, to make evidence-based clinical decisions regarding treatment and management, and to more completely address the needs of psoriasis patients.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  psoriasis; suicidal ideation and behavior; suicidality

Mesh:

Year:  2018        PMID: 30315629     DOI: 10.1111/dth.12771

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  10 in total

1.  Risk for incident suicidality among psoriasis patients: a systematic review and meta-analysis.

Authors:  Wei-Kai Hung; Tao-Hsin Tung; Tzu-Yu Wang; Shih-Cheng Liao; Ching-Chi Chi
Journal:  Arch Dermatol Res       Date:  2022-08-12       Impact factor: 3.033

2.  Dextromethorphan Exhibits Anti-Inflammatory and Immunomodulatory Effects in a Murine Model: Therapeutic Implication in Psoriasis.

Authors:  Yi-Ming Chen; I-Chieh Chen; Ya-Hsuan Chao; Hsin-Hua Chen; Po-Ku Chen; Shih-Hsin Chang; Kai-Jieh Yeo; Shiow-Jiuan Wey; Chi-Chien Lin; Der-Yuan Chen
Journal:  Life (Basel)       Date:  2022-05-07

3.  Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians.

Authors:  Charlotte Read; April W Armstrong
Journal:  JAMA Dermatol       Date:  2020-07-01       Impact factor: 10.282

4.  Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.

Authors:  Glenn Haugeberg; Brigitte Michelsen; Arthur Kavanaugh
Journal:  RMD Open       Date:  2020-05

Review 5.  Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families.

Authors:  Chan Ho Na; Janice Chung; Eric L Simpson
Journal:  Children (Basel)       Date:  2019-12-02

6.  Validation of the Skindex-17 quality of life assessment instrument for a Brazilian population.

Authors:  Marilia Formentini Scotton Jorge; Ioana Bittencourt Mourão; Camila Fernandes Pollo; Ticiane Dionízio de Sousa; Silmara Meneguin; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-11-18       Impact factor: 1.896

7.  [Screening for mental comorbidities in dermatology : Successful implementation of a screening for mental comorbidities in the field of inpatient dermatological treatment].

Authors:  Felix-Wilhelm Köster; Sebastian Kohlmann; Siobhan Loeper; Bernd Löwe; Stefan W Schneider
Journal:  Hautarzt       Date:  2021-03       Impact factor: 0.751

8.  The Impact of Pruritus on the Quality of Life and Sleep Disturbances in Patients Suffering from Different Clinical Variants of Psoriasis.

Authors:  Kamila Jaworecka; Marian Rzepko; Luiza Marek-Józefowicz; Funda Tamer; Aleksandra A Stefaniak; Magdalena Szczegielniak; Joanna Chojnacka-Purpurowicz; Ayla Gulekon; Jacek C Szepietowski; Joanna Narbutt; Agnieszka Owczarczyk-Saczonek; Adam Reich
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

9.  A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis.

Authors:  Emily K Haque; Aaminah Azhar; John Corbett; Jillian Frieder; Xuan Wang; Alan Menter
Journal:  Dermatol Ther (Heidelb)       Date:  2020-08-20

10.  The Relationship between Alexithymia and Mental Health Is Fully Mediated by Anxiety and Depression in Patients with Psoriasis.

Authors:  Rossella Mattea Quinto; Francesco De Vincenzo; Dario Graceffa; Claudio Bonifati; Marco Innamorati; Luca Iani
Journal:  Int J Environ Res Public Health       Date:  2022-03-19       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.